Minerva Surgical Inc UTRS shares are soaring Wednesday morning after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
The Details: Minerva Surgical was granted U.S. patent #11653972 for "Medical Systems And Methods (For Resecting And Extracting Tissue)."
The patent describes a process in which tissue is resected and extracted from a patient's body using a tool which uses vaporization to propel the tissue through an extraction lumen of the resecting device.
"Resection is achieved using an electrosurgical electrode assembly including a first electrode on a resecting member and a second electrode within a resection probe or tool," the patent states.
The first resecting portion involves a radio frequency current and the second portion involves vaporization of fluids by radio frequency which then propels the tissue from the device.
"In one embodiment, an extending element extends from a housing and into a channel in a resecting member as the resecting member moves toward a distal position," the patent states.
Minerva is a commercial-stage medical technology company focused on developing, manufacturing and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women.
See Also: Why Novavax, Pfizer And BioNTech Shares Are Rising Today
UTRS Price Action: Minerva shares were up 183.4% at 52 cents at the time of writing, according to Benzinga Pro.
Photo: Lorenzo Cafaro from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.